People: Isis Pharmaceuticals, Inc. (ISIS.O)
ISIS.O on Nasdaq
11.04USD
9 Feb 2010
11.04USD
9 Feb 2010
Price Change (% chg)
$0.04 (+0.36%)
$0.04 (+0.36%)
Prev Close
$11.00
$11.00
Open
$11.16
$11.16
Day's High
$11.24
$11.24
Day's Low
$10.97
$10.97
Volume
693,619
693,619
Avg. Vol
1,136,536
1,136,536
52-wk High
$18.81
$18.81
52-wk Low
$9.77
$9.77
DiMarchi, Richard
Brief Biography
Richard D. DiMarchi, Ph.D., has served as a Director of Isis Pharmaceuticals Inc since December 2004. Dr. DiMarchi has been a Professor and the Jack and Linda Gill Distinguished Chair in Biomolecular Science at Indiana University, Bloomington, Indiana since August 2003. He previously served as Chairman of the Chemistry Department, and is a co-founder of Marcadia Biotech and Ambrx, Inc., privately held biotechnology companies. Prior to joining Indiana University, Dr. DiMarchi worked for 22 years at Eli Lilly and Company in several senior management positions, including Group Vice President, Biotechnology and Product Development, from 1996 to 2003, and Vice President, Endocrine Research and Clinical Investigation, from 1992 to 1996.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
| Crooke, Stanley | 2,290,190 |
| Parshall, B. Lynne | 1,476,060 |
| Bennett, C. Frank | 799,256 |
| Geary, Richard | 665,625 |
| Wender, Joseph | -- |
| Reed, John | -- |
As Of 30 Dec 2008





